These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 33621527

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, Zhang Y.
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [Abstract] [Full Text] [Related]

  • 24. BSMI single nucleotide polymorphism in vitamin D receptor gene is associated with decreased circulatory levels of serum 25-hydroxyvitamin D among micro and macrovascular complications of type 2 diabetes mellitus.
    Ezhilarasi K, Dhamodharan U, Vijay V.
    Int J Biol Macromol; 2018 Sep; 116():346-353. PubMed ID: 29738868
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes.
    Wu X, Niu N, Brismar K, Zhu X, Wang X, Efendic S, Du T, Liu Y, Gu HF, Liu Y.
    Clin Biochem; 2009 Jan; 42(1-2):17-21. PubMed ID: 19007767
    [Abstract] [Full Text] [Related]

  • 26. The association of interieukin-6 polymorphism (rs1800795) with microvascular complications in Type 2 diabetes mellitus.
    Cui J, Zhang X, Guo C, Zhang L.
    Biosci Rep; 2020 Oct 30; 40(10):. PubMed ID: 33016995
    [Abstract] [Full Text] [Related]

  • 27. The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics.
    Dlouha L, Pelikanova T, Veleba J, Adamkova V, Lanska V, Sosna T, Pacal L, Kankova K, Hubacek JA.
    Mol Biol Rep; 2021 Aug 30; 48(8):5873-5879. PubMed ID: 34328600
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
    Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, Tao Q, Zhang Y.
    Lipids Health Dis; 2016 Sep 15; 15(1):158. PubMed ID: 27633510
    [Abstract] [Full Text] [Related]

  • 30. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes.
    Choe EY, Wang HJ, Kwon O, Kim KJ, Kim BS, Lee BW, Ahn CW, Cha BS, Lee HC, Kang ES, Mantzoros CS.
    Metabolism; 2013 May 15; 62(5):677-85. PubMed ID: 23260797
    [Abstract] [Full Text] [Related]

  • 31. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, Hattersley AT, Stoffel M.
    Diabetes; 2003 Dec 15; 52(12):2989-95. PubMed ID: 14633861
    [Abstract] [Full Text] [Related]

  • 32. Association of resistin (rs3745367) and urotensin II (rs228648 and rs2890565) gene polymorphisms with risk of type 2 diabetes mellitus in Indian population.
    Kumar V, Singh J, Bala K, Singh J.
    Mol Biol Rep; 2020 Dec 15; 47(12):9489-9497. PubMed ID: 33269434
    [Abstract] [Full Text] [Related]

  • 33. Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; evidence from Kurdish patients with type 2 diabetes mellitus.
    Amini S, Javanmardi M, Mokarizadeh A, Maroofi F, Jalali C, Azadi NA, Mohammadi H, Abdi M.
    QJM; 2016 Jun 15; 109(6):399-404. PubMed ID: 26337659
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases.
    Zheng L, Luo G, Zhang X, Zhang J, Zhu J, Wei J, Mu Q, Chen L, Nilsson-Ehle P, Xu N.
    Int J Gen Med; 2009 Dec 29; 2():177-82. PubMed ID: 20360902
    [Abstract] [Full Text] [Related]

  • 37. The association between apolipoprotein M and insulin resistance varies with country of birth.
    Memon AA, Bennet L, Zöller B, Wang X, Palmér K, Dahlbäck B, Sundquist J, Sundquist K.
    Nutr Metab Cardiovasc Dis; 2014 Nov 29; 24(11):1174-80. PubMed ID: 24984825
    [Abstract] [Full Text] [Related]

  • 38. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes.
    Buraczynska M, Wacinski P, Zukowski P, Dragan M, Ksiazek A.
    J Diabetes Complications; 2014 Nov 29; 28(1):35-9. PubMed ID: 24075694
    [Abstract] [Full Text] [Related]

  • 39. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
    Jiao GQ, Yuan ZX, Xue YS, Yang CJ, Lu CB, Lu ZQ, Xiao MD.
    Clin Biochem; 2007 Oct 29; 40(15):1108-12. PubMed ID: 17674965
    [Abstract] [Full Text] [Related]

  • 40. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.
    Shokouhi S, Delpisheh A, Haghani K, Mahdizadeh M, Bakhtiyari S.
    Clin Lab; 2014 Oct 29; 60(8):1269-76. PubMed ID: 25185411
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.